EGFR and cancer: Following treatment with TGFα, we observed in MSCs a significant enrichment in several pathways, such as TGFβ signaling, focal adhesion, Rap1 signaling, Hippo signaling, mTOR and RAS signaling, indicating that the EGFR system modulated in MSCs miRNAs potentially involved in cancer development and progression.